SABS - Balance Sheet - SAB Biotherapeutics, Inc.

Current Liabilities	7.98 M
Accounts Payable	1.69 M
Short-Term Debt	812 K
Other Current Liabilities	5.47 M
Non-Current Liabilities	10.2 M
Long-Term Debt	0
Other Non-Current Liabilities	10.2 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019
ASSETS
Cash & Cash Equivalents	8.9	56.6	15.0	33.2	12.6	6.3
Short Term Investments	11.9	0	0	0	0	0
Receivables	55 K	0	5.6	8.0	20.6	2.8
Inventory	0	0	0	0	0	0
Other Current Assets	3.0	2.3	1.5	9.0	1.3	0.1
Total Current Assets	23.8	58.9	22.1	48.4	34.5	9.3
PP&E	19.9	24.7	28.3	30.9	22.1	8.7
Intangible Assets	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	0
Other Long Term Assets	0.5	0.4	0.5	0	0	0
Other Assets	0	0	0	0	0	0
Total Assets	44.2	83.9	50.9	79.4	56.5	18.0
LIABILITIES
Accounts Payable	1.7	0.9	3.7	4.5	7.4	2.2
Short Term Debt	0.8	1.9	2.0	3.1	1.7	1.9
Other Current Liabilities	5.5	6.7	9.2	16.8	1.9	(4.1)
Total Current Liabilities	8.0	10.8	15.0	24.7	11.1	4.6
Long Term Debt	0	4.1	4.5	5.4	6.5	53.4 K
Deferred Tax Income	0	0	0	0	0	0
Other Liabilities	10.2	11.8	0.3	10.7	0	15.6
Total Liabilities	18.2	26.6	19.8	40.8	17.5	20.3
EQUITY
Common Stock	935	929	5.09 K	4.35 K	3.52 K	3.52 K
Retained Earnings	(124.2)	(90.1)	(47.9)	(29.1)	(12.0)	(32.1)
Other Accumulative Comprehensive Income/Loss	(0.1)	26.4 K	0	0	0	0
Total Equity	26.0	57.3	31.1	38.5	39.0	(2.3)
Total Liabilities and Equity	44.2	83.9	50.9	79.4	56.5	18.0
SHARES OUTSTANDING
Common Shares Outstanding	9.3	5.5	4.4	2.7	2.5	43.5

Free